Cook Spectrum G24137Recalls & reported problems
Cook Incorporated · Spectrum, Central Venous Tray Minocycline/Rifampin Impregnated Triple Lumen Polyurethane Catheter · Class 2
All models of Cook Spectrum (67)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00827002241374), received between Sep 7, 2017 and Jun 26, 2020 — classified as 3 injuries, 1 malfunction.
The most frequently reported specific device problem is “Crack” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Crack1
- Deformation Due to Compressive Stress1
- Leak/Splash1
- Obstruction of Flow1
Patient problems
- No Code Available3
- Death1
- Extravasation1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryJun 26, 2020Deformation Due to Compressive Stress; Deformation Due to Compressive Stress
IT WAS REPORTED THAT THE WIRE GUIDE OF A COOK SPECTRUM MINOCYCLINE/RIFAMPIN IMPREGNATED TRIPLE LUMEN CENTRAL VENOUS CATHETER WAS NOTED TO BE KINKED AFTER A DIFFICULT REMOVAL FROM THE PATIENT. THE PATIENT CODED UPON REMOVAL BUT SURVIVED WITH NO "KNOWN TRAUMA". AN ANESTHESIOLOGIST WAS PLACING A CENTRAL LINE IN A PATIENT IN THE INTENSIVE CARE UNIT (ICU). SHE INSERTED THE CATHETER AND THEN ATTEMPTED TO REMOVE THE WIRE GUIDE BUT FOUND "IT WOULD NOT COME OUT". AFTER MULTIPLE REMOVAL ATTEMPTS, SHE HAD TO "REMOVE THE ENTIRE LINE AND WHEN SHE DID THE PATIENT CODED". IT IS UNKNOWN AT THIS TIME WHAT ACTIONS WERE TAKEN TO TREAT THE PATIENT, BUT THE PATIENT DID SURVIVE THE CODE. IT WAS REPORTED THERE WAS NO "KNOWN TRAUMA CAUSED BY THE WIRE". UPON INSPECTION OF THE REMOVED WIRE, THE WIRE WAS NOTED TO BE BENT. ADDITIONAL INFORMATION REGARDING PATIENT AND EVENT DETAILS HAS BEEN REQUESTED BUT IS NOT AVAILABLE AT THIS TIME.
Patient problems: No Code Available
MAUDE report 10201483 ↗InjuryFeb 20, 2019Obstruction of Flow; Obstruction of Flow
IT WAS REPORTED THAT THE CATHETER FROM A COOK SPECTRUM MINOCYCLINE/RIFAMPIN IMPREGNATED TRIPLE LUMEN CENTRAL VENOUS CATHETER TRAY COILED WITHIN THE VESSEL. PATIENT DEATH OCCURRED MORE THAN 48 HOURS AFTER THE COILING WAS NOTICED. THE DEVICE WAS PLACED IN THE RIGHT FEMORAL VEIN WITH ULTRASOUND GUIDANCE. THE DEVICE DRESSING WAS INTACT, SUTURES WERE IN PLACE AND A CHLORHEXIDINE SPONGE WAS APPLIED. BLOOD WAS ASPIRATED FROM ALL LUMENS AFTER PLACEMENT, BUT IT WAS NOTED THAT THE DISTAL LUMEN WAS SLUGGISH. CENTRAL VENOUS PRESSURE WAS MONITORED FROM THE DISTAL LUMEN, AND IT WAS FOUND THAT THE CENTRAL VENOUS PRESSURE TRACING WAS DAMPENED. THE CLINICIANS CONTINUED TO PROCEED WITH TREATMENT USING THIS DEVICE BECAUSE IT WAS INSERTED UNDER ULTRASOUND GUIDANCE. CLINICIANS THOUGHT THAT THE DISTAL LUMEN INTRAVASCULAR PORT WAS LYING AGAINST THE VESSEL WALL LEADING TO DAMPENING OF THE WAVE. NO INTERVENTIONS WERE PERFORMED AS A RESULT OF THE DAMPENING OF THE WAVE. MEDICATIONS ADMINISTERED THROUGH THIS DEVICE INCLUDED PHENYLEPHRINE, NOREPINEPHRINE, VASOPRESSIN, AND LACTATED RINGERS SOLUTION. SEVEN HOURS AFTER DEVICE PLACEMENT, THE PATIENT DEVELOPED HYPOTENSION. VASOPRESSORS WERE ADDED AND MAXED OUT GRAD
Patient problems: Death; Extravasation; No Code Available
MAUDE report 8354954 ↗InjuryMay 4, 2018Leak/Splash; Leak/Splash
NO ADDITIONAL INFORMATION HAS BEEN REPORTED SINCE THE SUBMISSION OF THE INITIAL REPORT ON 05/04/2018.
Patient problems: No Code Available
MAUDE report 7486088 ↗MalfunctionSep 7, 2017Crack; Crack
IT WAS REPORTED BY THE CUSTOMER THAT THERE WAS A CRACK IN THE HUB, WHICH RESULTED IN A CONTINUAL LEAK FROM THE PORT. THE CRACK WAS TAPED AND WRAPPED. BECAUSE THE PATIENT WAS REPORTEDLY DIFFICULT TO CATHETERIZE, THE CUSTOMER LEFT THE DEVICE IN AND PROVIDED CARE. THE ACCOUNT CONFIRMED THAT NO PATIENT ADVERSE EVENTS WERE REPORTED AS A RESULT OF THIS INCIDENT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6848731 ↗
Other Catheter,intravascular,therapeutic,short-term less than 30 days devices
- BD Insyte Autoguard 382523Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days660 reports
- BD Insyte Autoguard 382533Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days2 recalls527 reports
- BD PosiFlush 306546Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days1 death608 reports
- BD Insyte Autoguard Shielded IV Catheter 381823Becton, Dickinson And Company · Catheter, intravascular, therapeutic, short-term less than 30 days582 reports
- BD Insyte Autoguard 381423Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days1 recall528 reports
- BD Insyte Autoguard 382544Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days1 recall437 reports
- BD Nexiva, BD Q-Syte 383536Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days2 recalls374 reports
- BD PosiFlush 306547Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days2 recalls1 death331 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page